#ANZUP19 Highlights from Brisbane
While we were set a very high benchmark on the back of last year’s ASM,…
Browsing: GU Cancers
ASCO 2019: The eight biggest stories on anticancer agents
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
From urine samples to precision medicine in bladder cancer through 3-D cell culture
A research collaborative led by scientists from institutions in Japan including Tokyo University of Agriculture…
Bladder cancer: how we used a common cold virus to defeat it
Hardev Pandha, University of Surrey Non-muscle invasive bladder cancer is the tenth most common cancer…
ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer
A single arm, phase II clinical trial of 125 patients showed treatment with enfortumab vedotin…
Lifting the lid on bladder cancer support
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to…
Ipilimumab-heavy immunotherapy combination in metastatic bladder cancer
An immunotherapy combination with a higher dose of ipilimumab produced a 38 percent overall response…
Pain management protocol sends 92% of cancer surgery patients home without opioids
A specialised pain management program for patients who underwent robotic surgery for urologic cancers resulted…
How genomics profiling can help identify the best treatment for bladder cancer
When it comes to cancer, one-size-does-not-fit-all. “One of the challenges that we have when taking…
Quitting smoking is associated with reduced risk of bladder cancer in postmenopausal women
A large study of postmenopausal women indicated that quitting cigarette smoking was associated with significantly…